Boston Scientific Honored as One of the 'Top 20 High-Growth Enterprises with Outstanding Contributions in Pudong New Area 2022'

Shanghai, September 19, 2023 /PR Newswire/ -- Recently, the Pudong New Area of Shanghai held the 2023 Economic Outstanding Contribution Enterprise Award Ceremony, presenting nine major awards to enterprises, including Special Economic Contribution, Outstanding Contribution to Scientific and Technological Innovation, Outstanding Contribution to Advanced Manufacturing, and Outstanding Contribution by Private Enterprises. At the event, Boston Scientific was awarded the title of "Top 20 Outstanding Contribution High-Growth Enterprises in Pudong New Area for 2022." This follows Boston Scientific's recent recognition on the "2022 Top 100 Foreign-Invested Enterprises in Shanghai" list by the Shanghai Association of Foreign Investment, further affirming the company’s remarkable achievements in promoting high-quality development of the local economy and healthcare industry in China.

This year marks the 45th anniversary of China's reform and opening-up, and the increasingly open business environment in China has provided Boston Scientific with vast room for development. This year also commemorates the 10th anniversary of the establishment of China’s first free trade zone (FTZ) in Shanghai’s Pudong New Area. Over the past decade, the Shanghai FTZ has played a crucial role as a testing ground for comprehensively deepening reforms and expanding opening-up, becoming a "consumer market" for the medical device industry, a "source of innovation," and a "manufacturing hub." As one of the first foreign enterprises to settle in Pudong, Boston Scientific has been committed to achieving high-quality growth in sync with the Chinese market since entering it in 1997. The company has not only established its China headquarters and the first overseas R&D center in Shanghai but also positioned Shanghai as the strategic hub for its medical trade and investment in China. Through deep integration with industries, academia, research, and medical sectors, Boston Scientific has built a series of embedded, collaborative ecosystem-driven development strategies, earning widespread recognition — including being named a Model International Trade Distribution Center Enterprise in Shanghai, receiving the Outstanding Economic Contribution Award in Pudong New Area, and becoming a strategic partner in the Shanghai FTZ's Global Operator Program (GOP). Leveraging the Medical Device Registration Holder (MAH) system, Boston Scientific also celebrated the local production of its first product in 2022, marking a new phase in its localization efforts in China.

Currently, the Shanghai government is continuously advancing high-level opening-up and striving to create a world-class biopharmaceutical industrial cluster ecosystem. The Shanghai Free Trade Zone has outlined a new plan to establish an "International Medical Device Intelligent Manufacturing Base," aiming to foster new momentum for the development of international medical devices from trade-focused to an equal emphasis on trade and research-driven intelligent manufacturing. This aligns perfectly with Boston Scientific's ongoing efforts to deepen its localization process and actively expand its reach across the upstream and downstream segments of the industry value chain. In the future, Boston Scientific will further leverage the driving role of its Shanghai headquarters economy, transforming its Shanghai base into a strategic hub guided by headquarters leadership and supported by five integrated functions. It aims to expand its business in China from being primarily trade-focused to encompassing the entire value chain, including product development, production, diversified investments, and after-sales services, thereby supporting Shanghai in becoming a global innovation hub and a world-class cluster for the medical device industry.

Zhang Jun, President of Boston Scientific Greater China, stated: "This award is an affirmation from the Pudong New Area government to Boston Scientific and, more importantly, an encouragement for our continued efforts. The 33 years of Pudong's development and opening-up reflect the fruitful achievements of China's reform and opening-up and Shanghai's modernization. It is an honor to have witnessed Pudong's leading role in this process. We will continue to resonate with the times and be the most loyal partner of China’s healthcare industry, bringing more innovative medical solutions to the vast number of patients and doctors in China."

About Boston Scientific

Boston Scientific Corporation is committed to innovation for life. We are dedicated to innovative medical solutions that improve the lives of patients worldwide. For over four decades, Boston Scientific has consistently led the global medical technology industry by providing a wide range of high-performance medical solutions that address critical treatment needs for a broad patient population while reducing healthcare costs.

About Boston Scientific Greater China

Boston Scientific established its China headquarters in Shanghai in 1997 and currently has branches in Beijing, Guangzhou, Chengdu, Hong Kong, and Taipei. The company's core business areas cover cardiac intervention, structural heart disease, cardiac rhythm management, electrophysiology, endoscopic intervention, oncology intervention, peripheral intervention, urology, respiratory intervention, otolaryngology, and neuromodulation. Upholding the tradition of being an innovation leader, Boston Scientific is committed to becoming a medical technology company that meets the needs of doctors and patients, demonstrates innovative vitality, and commands respect by providing high-quality medical products and services for prevention, diagnosis, and treatment. For more detailed information, please visit the company’s website:www.bostonscientific.cn